Test Phantoms Market Overview
The Test Phantoms Market was valued at USD 218.82 Million in 2025 and is projected to reach USD 291.85 Million by 2032, growing at a CAGR of 4.2% during 2026–2032, with North America holding the largest share.
Primary Drivers
- Rising global installed base of CT, MRI, ultrasound, mammography and radiotherapy equipment drives recurring demand for quality-assurance and calibration phantoms.
- Stringent regulatory and accreditation requirements (FDA MQSA, ACR accreditation, IEC standards) mandate routine phantom-based QA testing across imaging facilities.
- Growth in radiotherapy planning, AI-based imaging algorithm validation and 3D-printed patient-specific phantoms is expanding phantom application scope and value.
Primary Challenges
- High cost of advanced anthropomorphic and multi-modality phantoms limits adoption among smaller diagnostic centers, especially in developing markets.
- Long replacement cycles, since phantoms are durable QA tools, constrain repeat-purchase revenue for manufacturers.
- Lack of standardized phantom protocols across regions and modalities creates fragmentation and complicates cross-border regulatory compliance.
This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Test Phantoms Market.
Test Phantoms Market Strategic Outlook
Phantom in medical term is a specially designed object that is imaged or scanned to evaluate, tune and analyse performance of various medical imaging devices. It is also uses to test new imaging methods with their performance in the laboratory before they are applied to human volunteers. Test Phantoms is used in various medical imagining process such as CT Test Phantoms, Mammography Test Phantoms, Ultrasound Test Phantoms, Radiation Oncology Test Phantoms, MRI Test Phantoms, Optical laser Phantoms.
Growth trajectory, 2026–2032
How this market is covered
Revenue split by type
Revenue by end use
Profshare Market Research Publishes in-depth market research report on Test Phantoms Market. The report comprises value chain analysis for each of the product segments. Value chain analysis offers in-depth information about value addition at each stage. The study includes drivers and restraints in Test Phantoms Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting the growth of the market
The market is expected to show constant growth between 2026 and 2032. The study covers a detailed analysis, growth and forecast of the Test Phantoms Market. The report includes market analysis on regional level. The study covers historical data analysis from 2020 and 2025 and market forecast for 2026 and 2032 based on revenue generated. The study includes market value in terms of revenue in billion USD for years 2018-2030 and compound annual growth rate (CAGR) in % from 2026 and 2032.
Research report includes major player analysis with shares of each player inside market, growth rate and market attractiveness in different end-users/regions. Our study on Test Phantoms Market helps users to make precise decision to expand their market presence and increase their market share. The competitive landscape in the report offers detailed profiles of the key players in Test Phantoms Market. The report also covers financial overview, market strategies, new product analysis and marketing trends. Precise Competitive analysis helps businesses to build new product strategies.
Test Phantoms Market: Product Type
- CT Test Phantoms
- Mammography Test Phantoms
- Ultrasound Test Phantoms
- Radiation Oncology Test Phantoms
- MRI Test Phantoms
Test Phantoms Market: Application / End User
- Research Institute
- School
- Hospital
- Clinics
Test Phantoms Market: Competitive Analysis
- Gammex
- Fluke
- IBA
- Standard Imaging
- Biodex Medical Systems
- RaySafe
- Capintec
- Pro-Project
- The Phantom Laboratory
- Carville
- CIRS
- Modus Medical Devices
- Radiology Support Devices
- 3-Dmed
- Kyoto Kagaku
Test Phantoms Market: Regional Analysis
- North America
- U.S.A
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
Diagnostic Imaging & Measurement Devices Landscape
Report Coverage
| Parameter | Details |
|---|---|
| Base Year | 2025 |
| Historical Data | 2020 – 2025 |
| Forecast Period | 2026 – 2032 |
| Base Year Value | USD 218.82 Million |
| Forecast Value | USD 291.85 Million |
| CAGR | 4.2% |
| Regional Scope | North America · Europe · Asia-Pacific · Latin America · MEA · RoW |
Frequently Asked Questions
Test Phantoms Market was valued at USD 218.82 Million in 2025 and is estimated to reach USD 291.85 Million by 2032.
Test Phantoms Market is projected to grow at a CAGR of 4.2% during 2025–2032.
Test Phantoms Market Report is dominated by the CT Test Phantoms segment and the North America region holds the highest market share in 2025.
Some of the top key players in the Test Phantoms Market Report are Gammex,Fluke,IBA,Standard Imaging,Biodex Medical Systems,RaySafe,Capintec,Pro-Project,The Phantom Laboratory,Carville,CIRS,Modus Medical Devices,Radiology Support Devices,3-Dmed,Kyoto Kagaku.
1. Rising global installed base of CT, MRI, ultrasound, mammography and radiotherapy equipment drives recurring demand for quality-assurance and calibration phantoms. 2. Stringent regulatory and accreditation requirements (FDA MQSA, ACR accreditation, IEC standards) mandate routine phantom-based QA testing across imaging facilities. 3. Growth in radiotherapy planning, AI-based imaging algorithm validation and 3D-printed patient-specific phantoms is expanding phantom application scope and value.
Yes. The report includes a dedicated section on geopolitical risk factors and their impact on supply chains, pricing, and regional demand dynamics.